 Anemia, Sickle Cell
"Anemia, Sickle Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Descriptor ID |
D000755
|
| MeSH Number(s) |
C15.378.071.141.150.150 C15.378.420.155 C16.320.070.150 C16.320.365.155
|
| Concept/Terms |
Anemia, Sickle Cell- Anemia, Sickle Cell
- Anemias, Sickle Cell
- Sickle Cell Anemias
- Hemoglobin S Disease
- Disease, Hemoglobin S
- Hemoglobin S Diseases
- Sickle Cell Anemia
- Sickle Cell Disorders
- Cell Disorder, Sickle
- Cell Disorders, Sickle
- Sickle Cell Disorder
- Sickling Disorder Due to Hemoglobin S
- HbS Disease
- Sickle Cell Disease
- Cell Disease, Sickle
- Cell Diseases, Sickle
- Sickle Cell Diseases
|
Below are MeSH descriptors whose meaning is more general than "Anemia, Sickle Cell".
- Diseases [C]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Anemia [C15.378.071]
- Anemia, Hemolytic [C15.378.071.141]
- Anemia, Hemolytic, Congenital [C15.378.071.141.150]
- Anemia, Sickle Cell [C15.378.071.141.150.150]
- Hemoglobinopathies [C15.378.420]
- Anemia, Sickle Cell [C15.378.420.155]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Anemia, Hemolytic, Congenital [C16.320.070]
- Anemia, Sickle Cell [C16.320.070.150]
- Hemoglobinopathies [C16.320.365]
- Anemia, Sickle Cell [C16.320.365.155]
Below are MeSH descriptors whose meaning is more specific than "Anemia, Sickle Cell".
This graph shows the total number of publications written about "Anemia, Sickle Cell" by people in this website by year, and whether "Anemia, Sickle Cell" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 3 | 0 | 3 | | 1994 | 1 | 0 | 1 | | 2000 | 2 | 0 | 2 | | 2002 | 0 | 1 | 1 | | 2004 | 2 | 0 | 2 | | 2005 | 3 | 0 | 3 | | 2007 | 1 | 0 | 1 | | 2008 | 5 | 1 | 6 | | 2009 | 2 | 1 | 3 | | 2010 | 4 | 1 | 5 | | 2011 | 13 | 1 | 14 | | 2012 | 5 | 0 | 5 | | 2013 | 3 | 0 | 3 | | 2014 | 15 | 0 | 15 | | 2015 | 11 | 1 | 12 | | 2016 | 7 | 0 | 7 | | 2017 | 8 | 1 | 9 | | 2018 | 9 | 0 | 9 | | 2019 | 10 | 0 | 10 | | 2020 | 9 | 0 | 9 | | 2021 | 10 | 1 | 11 | | 2022 | 9 | 0 | 9 | | 2023 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Anemia, Sickle Cell" by people in Profiles.
-
Fraley CE, McKinney C, Nuss R, Franklin ARK. Therapy Selection for Hodgkin Lymphoma in Sickle Cell Disease: balancing risks and benefits. Blood Adv. 2023 05 23; 7(10):2042-2046.
-
Fraley CE, Neiman JS, Feddersen CR, James C, Jones TG, Mikkelsen M, Nuss R, Schlenz AM, Winters AC, Green AL, Compas BE. Identifying patterns of neurocognitive dysfunction through direct comparison of children with leukemia, central nervous system tumors, and sickle cell disease. Pediatr Blood Cancer. 2023 06; 70(6):e30299.
-
Koskela-Staples NC, Evans C, Turner EM, Black LV, Fedele DA. The Association Between Caregiver Coping and Youth Clinic Attendance and Health-related Quality of Life in Pediatric Sickle Cell Disease. J Pediatr Hematol Oncol. 2023 May 01; 45(4):e433-e440.
-
Dampier CD, Telen MJ, Wun T, Brown RC, Desai P, El Rassi F, Fuh B, Kanter J, Pastore Y, Rothman J, Taylor JG, Readett D, Sivamurthy KM, Tammara B, Tseng LJ, Lozier JN, Thackray H, Magnani JL, Hassell KL. A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis. Blood. 2023 01 12; 141(2):168-179.
-
Earley EJ, Kelly S, Fang F, Alencar CS, Rodrigues DOW, Soares Cruz DT, Flanagan JM, Ware RE, Zhang X, Gordeuk V, Gladwin M, Zhang Y, Nouraie M, Nekhai S, Sabino E, Custer B, Dinardo C, Page GP. Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci. Br J Haematol. 2023 04; 201(2):343-352.
-
Schlenz AM, Thomas SJ, Gloston G, Lebensburger J, Maxwell SL, Kanter J. Sleep quality and pain in adolescents and young adults with sickle cell disease. J Clin Sleep Med. 2022 Dec 01; 18(12):2845-2853.
-
Hazegh K, Fang F, Kelly K, Sinchar D, Wang L, Zuchelkowski BE, Ufelle AC, Esparza O, Davizon-Castillo P, Page GP, Kanias T. Erythrocyte mitogen-activated protein kinases mediate hemolytic events under osmotic and oxidative stress and in hemolytic diseases. Cell Signal. 2022 11; 99:110450.
-
Moriconi C, Dzieciatkowska M, Roy M, D'Alessandro A, Roingeard P, Lee JY, Gibb DR, Tredicine M, McGill MA, Qiu A, La Carpia F, Francis RO, Hod EA, Thomas T, Picard M, Akpan IJ, Luckey CJ, Zimring JC, Spitalnik SL, Hudson KE. Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease. Br J Haematol. 2022 08; 198(3):574-586.
-
Song A, Wen AQ, Wen YE, Dzieciatkowska M, Kellems RE, Juneja HS, D'Alessandro A, Xia Y. p97 dysfunction underlies a loss of quality control of damaged membrane proteins and promotes oxidative stress and sickling in sickle cell disease. FASEB J. 2022 05; 36(5):e22246.
-
Lewis CV, Sellak H, Hansen L, Joseph G, Hurtado J, Archer DR, Jun HW, Brown LA, Taylor WR. Increasing nitric oxide bioavailability fails to improve collateral vessel formation in humanized sickle cell mice. Lab Invest. 2022 08; 102(8):805-813.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|